CIK 0001818794
- Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364883909
- Phone
- +1 781-786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $40,000
- in 1 filing
- Open-market sales, last 90 days
- $421,679
- in 7 filings, $422K under 10b5-1 plans
Net −$381,679. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-16 | Scalzo Richard William | Grant or award · Stock Option (right to buy) | +35,575 | 35,575 | ||
| 2020-08-07 | Lubner David Charles Director | Purchase · Series B Preferred Stock | +177,872 | $2.81 | $500K | 177,872 |
| 2020-08-07 | Klein Lawrence Otto Director | Purchase · Series B Preferred Stock | +35,574 | $2.81 | $100K | 35,574 |
| 2020-08-07 | Stehman-Breen Catherine Director | Purchase · Series B Preferred Stock | +35,574 | $2.81 | $100K | 35,574 |
| 2020-08-07 | Kersten Dirk Director | Purchase · Series B Preferred Stock | +5,336,179 | $2.81 | $15.0M | 5,336,179 |
| 2020-08-07 | HURWITZ EDWARD Director | Purchase · Series B Preferred Stock | +1,326,313 | $2.81 | $3.7M | 1,326,313 |
| 2020-08-07 | HURWITZ EDWARD Director | Purchase · Series B Preferred Stock | +70,492 | $2.81 | $198K | 70,492 |
| 2020-08-07 | HURWITZ EDWARD Director | Purchase · Series B Preferred Stock | +26,176 | $2.81 | $74K | 26,176 |
| 2020-07-31 | Lubner David Charles Director | Grant or award · Stock Option (right to buy) | +11,156 | 11,156 | ||
| 2020-07-31 | Lubner David Charles Director | Grant or award · Stock Option (right to buy) | +14,444 | 14,444 | ||
| 2020-07-31 | Klein Lawrence Otto Director | Grant or award · Stock Option (right to buy) | +11,156 | 11,156 | ||
| 2020-07-31 | Klein Lawrence Otto Director | Grant or award · Stock Option (right to buy) | +14,444 | 14,444 | ||
| 2020-07-31 | Stehman-Breen Catherine Director | Grant or award · Stock Option (right to buy) | +11,156 | 11,156 | ||
| 2020-07-31 | Stehman-Breen Catherine Director | Grant or award · Stock Option (right to buy) | +14,444 | 14,444 | ||
| 2020-07-31 | Kersten Dirk Director | Purchase · Series A Preferred Stock | +5,250,000 | $1.00 | $5.3M | 15,000,000 |
| 2020-07-31 | HURWITZ EDWARD Director | Purchase · Series A Preferred Stock | +4,893,347 | $1.00 | $4.9M | 13,980,992 |
| 2020-07-31 | HURWITZ EDWARD Director | Purchase · Series A Preferred Stock | +260,077 | $1.00 | $260K | 743,076 |
| 2020-07-31 | HURWITZ EDWARD Director | Purchase · Series A Preferred Stock | +96,576 | $1.00 | $97K | 275,932 |
Page 41 of 41 · 818 trades